We are pleased to invite investors and analysts to participate in our virtual event on Monday, 13 February 2023, highlighting Roche data presented at the virtual Angiogenesis, Exudation, and Degeneration 2023 Meeting, from 10th to 11th February.

 

16:30 – 18:00 CET / 15:30 – 17:00 GMT
10:30 – 12:00 pm EST / 7:30 – 9:00 am PST

 

An invitation with the detailed programme and registration link will follow soon.

 

 

Best regards,

 
Bruno Eschli
Head of Investor Relations

 		 Loren Kalm
Head of Investor Relations, North America


Roche Investor Relations 
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

 		Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

 
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com

 		Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com
  
Investor Relations North America 
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com		 

get the latest news and updates to your inbox.